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Background: There is increasing evidence for the effectiveness of structured psychological therapies for bipolar
disorder. To date however there have been no psychological interventions specifically designed for individuals with
early bipolar disorder. The primary objective of this trial is to establish the acceptability and feasibility of a new CBT
based intervention (Recovery focused CBT; RfCBT) designed in collaboration with individuals with early bipolar
disorder intended to improve clinical and personal recovery outcomes.
Methods and design: This article describes a single blind randomised controlled trial to assess the feasibility and
acceptability of RfCBT compared with treatment as usual. Participants will be recruited from across the North West
of England from specialist mental health services and through primary care and self referral. The primary outcome
of the study is the feasibility and acceptability of RfCBT as indicated by recruitment to target and retention to
follow-up as well as absence of untoward incidents associated with RfCBT. We also intend to estimate the effect
size of the impact of the intervention on recovery and mood outcomes and explore potential process measures
(self appraisal, stigma, hope and self esteem).
Discussion: This is the first trial of recovery informed CBT for early bipolar disorder and will therefore be of interest
to researchers in this area as well as indicating the wider potential for evaluating approaches to the recovery
informed treatment of recent onset severe mental illness in general.
Trial registration number: ISRCTN43062149Background
Bipolar disorder (BD) has a prevalence rate of 1.5% [1]
affecting over 1 million people in England alone [2]. In
addition to repeated periods of mania and depression
most individuals with BD experience extended periods
of distressing subsyndromal mood symptoms between
episodes [3-5]. Consequently BD has significant impact
emotionally and functionally [6] and constitutes a sub-
stantial financial burden to society: McCrone recently
estimated cost to the English economy at £5.2 billion
per annum [2].
The National Institute for Clinical Excellence has
recommended the provision of structured psychological
therapy for individuals with bipolar disorder [7]. To date,
controlled trials of structured psychological therapy have* Correspondence: s.jones7@lancaster.ac.uk
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reproduction in any medium, provided the orfocused on individuals with a chronic bipolar disorder.
For example, participants in the Lam et al. [8] cognitive
behaviour therapy (CBT) trial had experienced a mean
of 5.8 depressive and 5.5 manic episodes, whilst in
Miklowitz et al.’s [9] comparison of CBT with Family Fo-
cussed Therapy and Interpersonal and Social Rhythm
Therapy two thirds of the sample had more than 10 epi-
sodes of mania and depression at baseline assessment.
Although it might seem logical to focus an intervention
requiring significant therapist time on individuals with
an established illness course recent psychological models
of bipolar disorder suggest otherwise. It has been argued
by several researchers that associative mechanisms build
up over repeated mood episodes in BD such that later
episodes are both more readily triggered by psychosocial
circumstances previously linked to mood changes and
are also less likely to be mediated by cognitive processes
[10-12]. This suggests that cognitive-behavioural inter-
ventions may be more powerful when applied earlier intd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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lar emotional states are established. Consistent with this
research a recent study of CBT for relapse prevention in
bipolar disorder found a significant benefit only for
those with fewer episodes in a post hoc analysis [13].
Additionally, there is evidence that individuals with earl-
ier onset of bipolar disorder tend to have worse clinical
outcomes, leading to calls for more timely detection and
intervention [14,15].
Despite the arguments in favour of earlier treatment
there have to date been no RCT evaluations of CBT for
bipolar disorder specifically targeted at individuals early
in their illness course. The current study will fill this gap
employing an adapted CBT intervention for individuals
within the first five years since onset of bipolar disorder.
An earlier version of this intervention has already
proved to be acceptable and feasible in a single case
series of 7 bipolar participants [16]. Substantial reduc-
tions in subsyndromal symptoms were observed during
intervention and six month follow-up along with
changes in appraisal styles and stability of sleep/wake
cycles. This suggests that psychological intervention for
individuals early in their course of bipolar disorder is
both effective and acceptable to service users.
The present trial builds on this pilot work in a RCT
feasibility study but also extends the intervention to in-
corporate a clear focus on recovery outcomes (Recovery
focused CBT; RfCBT). Recovery in relation to mental
health has been defined as “a deeply personal, unique
process of changing one’s attitudes, values, feelings,
goals, skills and/or roles. It is a way of living a satisfying,
hopeful, and contributing life even with limitations
caused by the illness. Recovery involves the development
of new meaning and purpose in one’s life as one grows
beyond the catastrophic effects of mental illness” [17].
Consistent with this individuals with severe mental
health issues including bipolar disorder have highlighted
the importance of increased hope, sense of control and
sense of social connectedness in recovery in contrast
with a traditional psychiatric focus on symptomatic out-
comes [18-21]. Recovery informed interventions are now
encouraged by the UK Government as a mechanism for
improving service provision in mental health through
personalised care based on individual needs [22,23]. Key
elements of this approach include choice, self-
determination and self-management [24] through which
the client is supported to plan their own route to recov-
ery [23].
Research into recovery and quality of life shows that
individuals with bipolar disorder highlight the import-
ance of functional as well as symptom outcomes [21,25];
with a particular focus on engaging or re-engaging in
valued activities including employment. Since the very
high societal cost of bipolar disorder is driven in largepart by loss to the workplace of individuals who could
otherwise contribute significantly, supporting individuals
in their recovery goals could have clear societal as well
as individual benefits. The intervention described in this
study was therefore developed based on evidence-based
principles for effective psychological interventions for bi-
polar disorder [26], our pilot case series work and
through qualitative interviews, focus group work and
consultation with individuals with experience of bipolar
disorder.
In this study we evaluate the feasibility and acceptabil-
ity of delivering RfCBT to individuals with bipolar dis-
order within 5 years of diagnosis. As a feasibility study
we primarily evaluate recruitment into the study and
consent to participate, adherence to the intervention, re-
tention within both arms across assessment, intervention
and follow-up periods and outcome parameter estimates.
From this we will be able to assess the acceptability of
the intervention to service users. In addition, the trial
will also provide preliminary indications of the impact of
RfCBT on self-reported recovery, bipolar relapse, mood
symptoms and functioning to inform the selection of
primary outcomes for a future definitive RCT.
Method
This trial is conducted by a multidisciplinary team of
researchers, clinicians, statistician and therapists across
academic institutions and NHS Trusts in the North
West of England. This study was reviewed and approved
by the UK NHS Ethics Committee process (REC ref: 10/
H1014/60).
Objective
To determine the feasibility and acceptability of a recov-
ery informed cognitive behaviour therapy intervention
(RfCBT) for bipolar disorder compared with treatment
as usual.
Main research questions:
 To demonstrate feasibility of recruitment and
consenting procedures, adherence to protocol and
retention to both arms of the trial across
assessment, intervention and follow-up periods.
 To provide parameter estimates of clinical outcomes
with respect to, recovery, bipolar relapse, mood,
cognitive style, quality of life, functioning, hope,
stigma and self esteem, post traumatic growth and
medication adherence.
Trial design
A rater-blind randomised controlled trial which com-
pares: i) Up to 18 h of RfCBT for bipolar disorder with;
ii) treatment as usual.
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recruitment across this region sampling individuals
across rural and urban settings with varied sociodemo-
graphic status and ethnic mix.
Randomisation is carried out by the independent Clin-
ical Trials Unit at The Christie NHS Foundation Trust,
Manchester, with minimisation on number of bipolar
episodes and level of current mood symptoms (including
depression and mania). These minimisation variables
were selected as there is preliminary evidence that clin-
ical outcomes are better in bipolar disorder for indivi-
duals with fewer episodes [13] and with less severe
mood problems at inception (although this research is
clearest with respect to symptoms of depression the high
rates of manic symptoms found in individuals in
depressed states indicates the importance of allowing for
both affective poles [27,28]).
Sample size
As the primary purpose of the study is to evaluate the
feasibility and acceptability of delivering the proposed
intervention a formal power calculation is not appropri-
ate. It has been estimated that 30 participants per group
will be sufficient to be able to reliably determine primary
feasibility outcomes. The recruitment target is set at 72
participants in total to allow for expected attrition rates
and measures of clinical outcome will be recorded at
baseline and follow-up to provide an indication of the ef-
fectiveness of the intervention in enhancing recovery,
regulating mood and its impact on other clinical out-
comes. This number will also allow us to evaluate the
secondary objective of the trial; to estimate the potential
treatment effect size as the basis and justification for a
substantive trial.
Recruitment
Eleven NHS Trusts in the North West UK are taking
part in this study (Greater Manchester Mental Health
NHS Foundation Trust, Bolton Primary Care Trust, Sal-
ford Primary Care Trust, Trafford Primary Care Trust,
Manchester Mental Health and Social Care Trust, Man-
chester Primary Care Trust, Lancashire Care NHS Foun-
dation Trust, North Lancashire Primary Care Trust, 5
Boroughs Partnership NHS Foundation Trust, Cumbria
Partnership NHS Foundation, Cumbria Primary Care
Trust). Community mental health teams, out-patient
clinics, GP surgeries, primary care mental health teams
and voluntary services are approached to identify poten-
tial participants. Care co-ordinators, research nurses and
research development officers are also approached in
order to contact potential participants in the first in-
stance. When recruiting in community mental health
teams and voluntary services, a member of the research
team presents an outline of the study and provideswritten material about the study. Potential participants
are offered a participant information sheet by their care
co-ordinators or the research team, outlining the study
and their role should they wish to take part.
The study is also advertised in local media and posters
and leaflets distributed in both NHS and non NHS sites
to maximise participant access. Care co-ordinators and
other relevant health professionals are informed of a par-
ticipant’s involvement in the study subject to participant
consented. If a participant does not wish for their GP or
care coordinator to be informed about their involvement
in the study, this does not prevent their participation
and contact details of all health professionals involved in
their care are still taken in case of any clinical adverse
events during the study. Participants are made aware on
entry to the study that their care co-ordinator will be
contacted should they be a significant risk to themselves
or others during the study.
Inclusion/exclusion criteria
Potential participants must meet the inclusion criteria
of:
 DSM-IV diagnosis of primary bipolar disorder with
onset in last 5 years [29].
 Sufficient understanding of written and spoken
English in order to provide consent, engage with
interviews and use the intervention.
 Aged between 18–65 years.
Exclusion criteria:
 Manic, hypomanic, depressed or mixed episode
currently or in the last four weeks
Outcome measures
In order to evaluate the feasibility and acceptability of
delivering the RfCBT intervention to individuals with a
recent diagnosis of bipolar disorder (onset in last 5
years) the following data will be evaluated: levels of re-
cruitment into the trial; retention of participants in both
arms of the study and adherence to and completion of
the intervention. At baseline the Structured Clinical
Interview for DSM-IV is completed to confirm bipolar
diagnosis and to provide information on comorbid dis-
order diagnoses as well as information on sociodemo-
graphic variables. Measures of clinical outcome will be
recorded at baseline and follow-ups to provide an indi-
cation of the effectiveness of the intervention in increas-
ing time to bipolar relapse, self reported recovery score
and improving observer rated mood as primary clinical
outcomes. Secondary outcomes are levels of self
reported affective symptoms, functioning/quality of life
and medication adherence. Process measures are
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self-esteem and post trauma growth.
Primary clinical outcomes
Hypotheses for the primary clinical outcomes are that
RfCBT will: i) increase self reported recovery as mea-
sured by the Bipolar Recovery Questionnaire [30]; ii) in-
crease time to bipolar relapse measured by the
Structured Clinical Interview for Diagnosis: Research
Version (SCID DSM-IV: SCID Life [31]; iii) reduce
mood symptoms as measured by Hamilton Depression
Rating Scale (HAM-D) [32] and Bech-Rafaelsen Mania
Scale (MAS) [33].
Measurement of secondary outcomes
Hypotheses for secondary outcomes are that RfCBT will
improve; i) self reported mood symptoms as measured
by the Beck Depression Inventory (Second Edition)
(BDI-II)[34] and Internal States Scale (ISS) [35]; ii) Qual-
ity of life and social functioning as measured by Personal
and Social Functioning Scale [36] and the Brief Quality
of Life in Bipolar Disorder Questionnaire. (QoL.BD)
[25]; iii) Medication adherence measured by the Ste-
phenson Medical Adherence Questionnaire (MEDAD)
[37].
Process measures
It is hypothesised that RfCBT will improve clinical out-
comes through; i) reducing tendency towards positive
self appraisals as measured by the Hypomanic Interpre-
tations Questionnaire and Interpretations of Depression
Questionnaire(HIQ/IDQ) [38,39]; ii) reducing experi-
ences of stigma measured by the Hayward Stigma Ques-
tionnaire-Revised Version (HSQ) [40]; iii) increasing
hope and self-esteem as measured by the Herth Hope
Index [41] and the Self-Esteem Rating Scale (SERS) [42];
iv) increasing post trauma growth as measured by the
post trauma growth inventory [43].
Measures to assess therapeutic alliance and adherence to
treatment protocol
Engagement in therapy will be assessed by means of the
Work Alliance Inventory (short-form, therapist and cli-
ent versions; WAI-S) [44]. Treatment fidelity will be
assessed by both the Cognitive Therapy Scale Revised
version (CTS-R) [45] and the RfCBT Fidelity Scale spe-
cifically designed for the current study.Schedule of assessments
The follow-up period will be up to 18 months from ini-
tial randomisation. In addition to regular (3 monthly)
assessments to evaluate bipolar relapse, recovery and ob-
server rated mood: additional clinical outcome andprocess measures will be assessed at inception and then
6 monthly. See Figure 1 (CONSORT diagram) and
Table 1 for more details on the timing and type of spe-
cific assessments.Individual recovery focused CBT intervention
The intervention is informed by current evidence for
components of effective CBT interventions which in-
clude mood monitoring and awareness, regularisation of
routines, enhancing prodromal coping and problem
solving training [26,46]. Prior to this study we also com-
pleted a case series of CBT for first diagnosis bipolar cli-
ents (although this had a less specific recovery focus),
which indicated the importance of maintaining a very
flexible engagement approach, allowing time for full
consideration of meaning of diagnosis to the client, en-
gaging in coping skills reviews around subsyndromal
exacerbations as well as prior episodes and considering
the role of appraisals of fluctuations in affect. These les-
sons have also informed the final treatment manual. In
addition we have conducted qualitative interviews with
individuals about their experiences of recovery in bipolar
disorder [21] and focus groups with individuals with bi-
polar disorder to consult on the draft content, format
and supporting materials for the RfCBT intervention.
The intervention is delivered by mental health profes-
sionals trained to BABCP accreditation level in CBT or
equivalent. Duration of therapy is up to 18 h delivered
over a period of approximately six months at client’s
homes or mental health facilities according to client pre-
ference. Initial sessions are weekly, with later sessions
fortnightly. Sessions are typically 45–60 min long.
The following elements are contained within the man-
ual and reflect elements typically addressed in the course
of therapy although the relative emphasis on each elem-
ent is informed by the client’s formulation:
 Introducing the recovery approach to clients
 Collection of information about current and
historical mood and functioning
 Meaning and relevance of diagnosis
 Identification of recovery informed therapy goals
 Initial formulation of relationships between mood
experiences and progress towards recovery goals
 Identification and application of CBT techniques to
address and facilitate positive coping
 Consideration of wider functioning issues in relation
to recovery
 Development and completion of recovery plan
 Sharing lessons from therapy with key stakeholders
The therapy approach differs from standard CBT for
bipolar disorder in the following ways:




(minimised on number of previous 
episodes and severity of current 
mood symptoms)
Participants with a 
diagnosis of BD offered
RfCBT (6 month duration)
Participants with a 
diagnosis of BD offered 
TAU (6 month duration)
Baseline assessment of 
participants with diagnosis 
of BD 
Telephone Follow-up 
Assessment at 3 Months
Telephone Follow-up 
Assessment at 3 Months
Face to Face Follow-up 
Assessment at 6 Months
Telephone Follow-up 
Assessment at 9 Months
Face to Face Follow-up 
Assessment at 12 Months
Telephone Follow-up 
Assessment at 15 Months
Face to Face Follow-up 
Assessment at 18 Months
Face to Face Follow-up 
Assessment at 6 Months
Telephone Follow-up 
Assessment at 9 Months
Face to Face Follow-up 
Assessment at 12 Months
Telephone Follow-up 
Assessment at 15 Months
Face to Face Follow-up 
Assessment at 18 Months
Figure 1 CONSORT Diagram showing Design of the Study.
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than presuming a target of relapse prevention.
– Formulation driven idiosyncratic approach rather
than applying a very similar model of bipolar
experience across clients.
– Freedom to work within whatever model the client brings.
– Openness to address functioning and comorbidity
issues as well as mood problems.Analysis
Feasibility
As the primary purpose of the study is to evaluate the
feasibility and acceptability of delivering the proposed
intervention a formal power calculation comparing treat-
ment groups is not essential. With 72 subjects in total
the study will estimate a follow-up rate of 75% with pre-
cision +/−10%.
















Bipolar Recovery Questionnaire (BRQ) * - * - * - *
Time to bipolar relapse: weekly LIFE scores (SCID life) * * * * * * *
Hamilton Depression Rating Scale (HDRS) * * * * * * *
Bech-Refaelsen Mania Scale (MAS) * * * * * * *
Secondary Outcome Measures
Beck Depression Inventory (BDI) * - * - * - *
Internal States Scale (ISS) * - * - * - *
Brief Quality of Life in Bipolar Disorder Questionnaire
(QoL.BD)
* - * - * - *
Personal and Social Performance Scale (PSP) * - * - * - *
Stephenson Medication Adherence Interview (SMAI) * - * - * - *
Process Measures
Hypomanic Interpretations Questionnaire (HIQ) * - * - * - *
Interpretation of Depression Questionnaire (IDQ) * - * - * - *
Hayward Stigma Questionnaire – Revised Version
(HSQ)
* - * - * - *
Self Esteem Rating Scale (SERS) * - * - * - *
Herth Hope Inventory (HHI) * - * - * - *
Post Trauma Growth Inventory (PTGI) * - * - * - *
* Measure used at assessment.
- Measure not used at assessment.
(t) Telephone assessment.
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All therapy effects will first be estimated using the
intention-to-treat principle, supplemented by estimation
of the therapy effects in those participants who actually
receive the intervention via estimation of the Complier-
Average Causal effect or CACE [47,48]. Time to relapse
will be assessed by survival analysis (using either propor-
tional hazard or accelerated life-time models). Each of
the secondary outcome measures will be analysed with
analysis of covariance through the use of generalised lin-
ear models (the data distribution and link function being
dependent upon the outcome under consideration).
Adjustments for missing data will be made assuming
that the missing data mechanism is either ignorable or
latently ignorable [49].
Discussion
This study will provide important data for the develop-
ment and evaluation of a future definitive recovery fo-
cussed CBT trial for early bipolar disorder. The recovery
intervention that is the subject of this study has been
developed in partnership with individuals with lived ex-
perience of bipolar consistent with Mental Health Re-
search Network good practice guidelines [50] including
service user involvement in qualitative work on recovery
experiences, development of a recovery outcomemeasure and structure and format of the RfCBT inter-
vention. These meetings were in addition to the focus
group work referred to earlier. This level of engagement
of individuals with personal experience of bipolar dis-
order fits with the model of recovery approaches as
being empowering, individualised and grounded in the
individual’s own priorities and needs. In addition to this
important element, the intervention is also structured
around evidence based components of effective psycho-
logical therapy including developing strategies for early
warning signs of depression and mania and stabilisation
of activity and sleep where this meets clients’ needs. It
differs from standard CBT in that there is an explicit
focus on eliciting client goals which may not include re-
lapse prevention as primary, where in CBT this target is
assumed for all clients. There is also a strong emphasis
on formulation rather than applying a very similar model
of bipolar experience across clients, so the client route
through therapy is different depending on their needs,
giving the therapist freedom to work with whatever
model the client brings but in the context of offering
evidence based approaches. Therapists are also explicitly
permitted to focus on issues around functioning and
comorbidity as well as mood problems.
Strengths of the study include targeting a clearly
defined sample who are currently poorly served by
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onset bipolar disorder. It is also the first therapy for bi-
polar disorder which explicitly aims to enhance recovery
outcomes which are valued by service users and sup-
ported by government policy. Additionally, we have not
assumed expert clinician knowledge of the nature of re-
covery in bipolar disorder, but rather grounded the inter-
vention in the experience and knowledge that service
users have offered us with respect to recovery. The study
is also recruiting from across NHS primary and second-
ary care settings and through self referral so that find-
ings should be more representative than those that
solely focus on specialist mental health settings as only a
subset of individuals with bipolar disorder are in such
settings long term [51].
There are weaknesses to the study which would need
to be addressed in a definitive trial. Firstly, there is no
active treatment control group so that any indications of
effectiveness need to be interpreted with caution as we
will not know whether possible benefits are a function of
this specific treatment or structured treatment in gen-
eral. Secondly, the scale of the study allows us to follow
participants for up to 18 months following therapy com-
pletion. Longer follow-ups would be helpful to indicate
more definitively whether this intervention impacts on
relapse as well as recovery. Thirdly, the very individua-
lised nature of the intervention means that it was neces-
sary to devise a new measure specifically to explore
fidelity to a very individualised therapy protocol. As we
are uncertain how this will perform we have also used
the established CTS-R which might underestimate fidel-
ity in a flexible therapy of this type.
Despite these challenges, if the current study indicates
that RfCBT is feasible and has potential clinical benefits
it will be an important step towards developing
evidence-based recovery interventions for people with
bipolar disorder that have been lacking until now.
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